Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Novonesis and TurtleTree enter partnership to support commercialization of lactoferrin
16 Jul 2026
GlobeNewswire
Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development
16 Jul 2026
PR Newswire Association LLC.
HERVolution Therapeutics Presents Clinical Evidence of HERV-K Driving Metabolic Senescence at the International Congress on Obesity 2026
15 Jul 2026
GlobeNewswire
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
15 Jul 2026
PR Newswire Association LLC.
The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company's commitments under an incentive programme
15 Jul 2026
GlobeNewswire
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
15 Jul 2026
GlobeNewswire
Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S.
15 Jul 2026
PR Newswire Association LLC.
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
14 Jul 2026
PR Newswire Association LLC.
FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease
14 Jul 2026
GlobeNewswire
Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
14 Jul 2026
PR Newswire Association LLC.
New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease
13 Jul 2026
GlobeNewswire
Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial
13 Jul 2026
GlobeNewswire
Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)
13 Jul 2026
GlobeNewswire
Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil
13 Jul 2026
PR Newswire Association LLC.
AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities
13 Jul 2026
GlobeNewswire
Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference
13 Jul 2026
PR Newswire Association LLC.
Sectra achieves the highest level of security attestation for healthcare providers adopting cloud services in Germany
13 Jul 2026
GlobeNewswire
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
12 Jul 2026
PR Newswire Association LLC.
Novo Nordisk's denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026
11 Jul 2026
PR Newswire Association LLC.
Dayton Children's Hospital goes live with Sectra's ophthalmology solution to unify imaging across specialties
09 Jul 2026
PR Newswire Association LLC.
Sectra publishes Annual Report and Sustainability Report for 2025/2026
08 Jul 2026
PR Newswire Association LLC.
Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards
08 Jul 2026
PR Newswire Association LLC.
Wegovy® (semaglutide) label updated in Singapore with higher dose supported by STEP UP evidence
08 Jul 2026
Upcoming Events All Events
- July 2026
- Taipei: BIO Asia-Taiwan
- August 2026
- Online: Biotechgate Digital Partnering August 2026
- September 2026
- Marina Bay Sands: Asia Bio Partnering Forum